BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 29233263)

  • 21. Applications of click chemistry in radiopharmaceutical development.
    Walsh JC; Kolb HC
    Chimia (Aarau); 2010; 64(1-2):29-33. PubMed ID: 21137680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carbon-11 patents (2012-2022): synthetic methodologies and novel radiotracers for PET imaging.
    Nerella SG; Singh P; Tulja S
    Expert Opin Ther Pat; 2022 Jul; 32(7):817-831. PubMed ID: 35451896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Positron emission tomography radiotracers for imaging hypoxia.
    Wuest M; Wuest F
    J Labelled Comp Radiopharm; 2013; 56(3-4):244-50. PubMed ID: 24285331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Drug Discovery Portal: a resource to enhance drug discovery from academia.
    Clark RL; Johnston BF; Mackay SP; Breslin CJ; Robertson MN; Harvey AL
    Drug Discov Today; 2010 Aug; 15(15-16):679-83. PubMed ID: 20547242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alcohol medications development: advantages and caveats of government/academia collaborating with the pharmaceutical industry.
    Litten RZ; Ryan M; Falk D; Fertig J
    Alcohol Clin Exp Res; 2014 May; 38(5):1196-9. PubMed ID: 24689461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advancing Drug Discovery and Development Using Molecular Imaging (ADDMI): an Interest Group of the World Molecular Imaging Society and an Inaugural Session on Positron Emission Tomography (PET).
    Patel S; Schmidt K; Hesterman J; Hoppin J
    Mol Imaging Biol; 2017 Jun; 19(3):348-356. PubMed ID: 28417265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New methodologies for the preparation of carbon-11 labeled radiopharmaceuticals.
    Dahl K; Halldin C; Schou M
    Clin Transl Imaging; 2017; 5(3):275-289. PubMed ID: 28596949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Demystifying industry-academia collaboration.
    Gersdorf T; He VF; Schlesinger A; Koch G; Ehrismann D; Widmer H; von Krogh G
    Nat Rev Drug Discov; 2019 Sep; 18(10):743-744. PubMed ID: 31570836
    [No Abstract]   [Full Text] [Related]  

  • 29. Industry-Academia Partnership: The Synthesis and Solid-State Pharmaceutical Centre (SSPC) as a Collaborative Approach from Molecule to Medicine.
    McGlacken GP; Hayes S; Maguire AR; O'Halloran J; Hodnett K
    Chemistry; 2018 Jan; 24(2):499-503. PubMed ID: 29235704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The development of radiotracers for imaging sigma (σ) receptors in the central nervous system (CNS) using positron emission tomography (PET).
    Banister SD; Manoli M; Kassiou M
    J Labelled Comp Radiopharm; 2013; 56(3-4):215-24. PubMed ID: 24285328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biocatalysis in radiochemistry: Enzymatic incorporation of PET radionuclides into molecules of biomedical interest.
    da Silva ES; Gómez-Vallejo V; López-Gallego F; Llop J
    J Labelled Comp Radiopharm; 2018 Apr; 61(4):332-354. PubMed ID: 29231247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiochemistry for positron emission tomography.
    Rong J; Haider A; Jeppesen TE; Josephson L; Liang SH
    Nat Commun; 2023 Jun; 14(1):3257. PubMed ID: 37277339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advancing novel therapies for neurodegeneration through an innovative model for industry-academia collaborations: A decade of the Eisai-UCL experience.
    Atkinson PJ; Swami M; Ridgway N; Roberts M; Kinghorn J; Warner TT; Staddon JM; Takle AK
    Drug Discov Today; 2023 Oct; 28(10):103732. PubMed ID: 37541423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Academic collaborations with industry: lessons for the future.
    Reddy SSK; Chao S
    J Investig Med; 2020 Dec; 68(8):1305-1308. PubMed ID: 33168581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update on PET radiopharmaceuticals: life beyond fluorodeoxyglucose.
    Shiue CY; Welch MJ
    Radiol Clin North Am; 2004 Nov; 42(6):1033-53, viii. PubMed ID: 15488556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Industry-Academic Relationship in a New Era of Drug Discovery.
    Vallance P
    J Clin Oncol; 2016 Oct; 34(29):3570-3575. PubMed ID: 27458309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiopharmaceutical chemistry for positron emission tomography.
    Li Z; Conti PS
    Adv Drug Deliv Rev; 2010 Aug; 62(11):1031-51. PubMed ID: 20854860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and biological evaluation of potential 5-HT(7) receptor PET radiotracers.
    Andries J; Lemoine L; Le Bars D; Zimmer L; Billard T
    Eur J Med Chem; 2011 Aug; 46(8):3455-61. PubMed ID: 21620533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiopharmaceuticals in positron emission tomography: present situation and future perspectives.
    Olivas Arroyo C
    Radiologia; 2016; 58(6):468-480. PubMed ID: 27592111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Importance of Collaboration between Industry, Academics, and Nonprofits in Tropical Disease Drug Discovery.
    Ferrins L; Pollastri MP
    ACS Infect Dis; 2018 Apr; 4(4):445-448. PubMed ID: 29134797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.